video platformvideo managementvideo solutionsvideo player Share this:EmailPrintFacebookStumbleUpon
Share this:EmailPrintFacebookStumbleUpon
Micah Materre WGN-TV News 3:51 p.m. CDT, August 19, 2011 If you didn’t know Paul Ruby, it would be tough to tell the 48-year-old hotel manager suffers from Parkinson’s Disease. The neurological disease affects people in different ways, and in Paul’s case, he moves a bit slower and talks softer. But to him, that’s not the worst of it. “Smiling,
Read more…
Hope For Parkinson’s Patients Offered By Stem Cell Study – MediLexicon. Share this:EmailPrintFacebookStumbleUpon
WGN 9 PM News to Feature Ruby Foundation – Batavia, IL Patch. WGN News at 9 p.m. on Friday, Aug. 19, will feature the Paul Ruby Foundation during its Chicago’s Very Own segment with Micah Materre. The segment will feature Kayleigh Barnaba, a 13-year-old Geneva resident who has raised over $500 for the Foundation, Wes Ruby, Paul’s son, who influenced
Read more…
By FRANK VINLUAN, MedCity News Research Triangle Park, N.C. — An investigational Parkinson’s disease treatment licensed by GlaxoSmithKline (NYSE: GSK) is now slated for a fourth quarter new drug application with the U.S. regulators following positive late-stage clinical trial results. British pharmaceutical giant GSK, which has its U.S. headquarters in Research Triangle Park, is partnering with California-based Impax Pharmaceuticals, a
Read more…
Katie Couric Is Honorary National Chair Of National Parkinson Foundation’s Moving Day | Press Release | Rehab Management. MIAMI, August 15, 2011 /PRNewswire-USNewswire/ — Katie Couric has agreed to be the honorary national chair of the National Parkinson Foundation’s (NPF) inaugural Moving Day campaign. Moving Day is the first grassroots campaign to spotlight Parkinson’s disease (PD) awareness on a national
Read more…
Share this:EmailPrintFacebookStumbleUpon
Share this:EmailPrintFacebookStumbleUpon
Michael J. Fox lights up Empire State Building for Parkinson’s Disease | Video | 7online.com. Share this:EmailPrintFacebookStumbleUpon
Fox lights up Empire State Building | Orange UK. Share this:EmailPrintFacebookStumbleUpon
Parker’s Climb. Share this:EmailPrintFacebookStumbleUpon
Share this:EmailPrintFacebookStumbleUpon
Share this:EmailPrintFacebookStumbleUpon
Novel Targeted Therapies Hold the Promise of Cure for Parkinson’s… – Topix. Share this:EmailPrintFacebookStumbleUpon
var r_protocol=((“https:”==document.location.protocol)?”https://”:”http://”);var r_path=’www.razoo.com/javascripts/widget_loader.js’;var r_identifier=’Defeat-Parkinsons-For-Brother–Michael-Justak’;document.write(unescape(“%3Cscript id=’razoo_widget_loader_script’ src=’”+r_protocol+r_path+”‘ type=’text/javascript’%3E%3C/script%3E”)); Share this:EmailPrintFacebookStumbleUpon
ScienceDaily (Mar. 9, 2011) — In a major breakthrough in the battle against Parkinson’s disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans. “Drugs currently used to treat Parkinson’s disease just treat symptoms; they do not stop the
Read more…
Protein pathway may hold a clue for understanding Parkinson’s disease 1. March 2011 00:59 A protein pathway that may hold the secret to understanding Parkinson’s disease has been discovered and explained by Iowa State University researchers. Anumantha Kanthasamy, a distinguished professor of biomedical sciences and the W. Eugene and Linda R. Lloyd Endowed Chair in Neurotoxicology at the ISU College
Read more…
Partnerships for Parkinson’s, the non profit begun by Mike Justak, will donate a Nintendo Wii game system along with its Wii Fit balance board, to an early onset Parkinson’s patient Friday 2/25 at the Struthers Parkinson’s Center of Golden Valley, MN. The donation and how use of the Wii system can improve the lives of those who live with PD
Read more…
Nintendo’s Wii Fit™ and I started off on the wrong foot when it called me “obese” and calculated my Wii Fit™ age to be 74! It arrived at this number after comparing my body test results with the “average results of an ideally fit person in my age bracket.” Now how fair is this for people with Parkinson’s? Still, I
Read more…
A business analyst who was struck down with debilitating Parkinson’s disease has overcome her symptoms – by using the Nintendo Wii. High-flying Jo Collinge, 48, was diagnosed with the disease 18 months ago after her shakes and sleeplessness were originally blamed on executive stress. The trembles in her right leg became so bad she could not walk across her daughter’s
Read more…
Successful intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded significant improvement in motor function and reversed the dopamine deficiency characteristic of the disease. These highly promising findings, reported in Rejuvenation Research, a peer-reviewed journal published by Mary Ann Liebert, Inc. highlight the potential for a noninvasive approach to cell therapy delivery in Parkinson disease
Read more…
Emerging Healthcare Solutions, Inc. (PinkSheets:EHSI) applauded a new study revealing a promising new stem cell treatment for Parkinson’s. The exciting findings, published in the stem cell journal Rejuvenation Research, detailed the successful intranasal delivery of stem cells into the brains of rats with Parkinson’s disease. The tests yielded significant improvement in motor function and reversed the characteristic dopamine deficiency of
Read more…
Berries May Offer Sweet Protection Against Parkinson’s Disease They’re rich in an antioxidant that seems to shield men and women from the illness, study finds By Steven Reinberg HealthDay Reporter SUNDAY, Feb. 13 (HealthDay News) — People who eat foods rich in antioxidants called flavonoids, especially berries, may be protecting themselves from developing Parkinson’s disease, a new study suggests. In
Read more…
Partnerships for Parkinson’s, PFP Inc’s blog has been named one of the top blogs of 2010 by Medical Transcription. MedicalTranscription.net Share this:EmailPrintFacebookStumbleUpon
FOUNDATION FUNDS ZYMES, LLC, TO DEVELOP NEW FORMULATION OF CoQ10 The antioxidant CoQ10 has been the subject of investigation as a potentially disease-modifying therapy for PD for years. Based on available evidence, extremely high doses may be required for an effect. This approach is currently being evaluated in an NIH-funded clinical study vetting common formulations of CoQ10 as a Parkinson’s
Read more…
May 28, 2009 Oslo Health Solutions: Preying On The Sick Part II This is Part II of my little exploration of a unscrupulous company who takes advantage of sick people by selling them herbal remedies under false pretenses. In part I, I told you about the products sold by Oslo Health Solutions, which is by far the worst offender out
Read more…
December 30, 2010 Dusseldorf, Germany (PRWEB) December 30, 2010 A personal doctor confirms spectacular improvements in Australian Parkinson’s patient, 61 year-old Stan Lahovec, after his successful stem cell treatment at the XCell-Center in Dusseldorf, Germany. Thanks to stem cell therapy, Mr. Lahovec is once again back to satisfying his true passion for oil painting.Stan Lahovec – Stem Cell Therapy for
Read more…
Share this:EmailPrintFacebookStumbleUpon
Newswise — Researchers at the University of Nebraska Medical Center have taken a significant step forward in developing a vaccination approach to reverse the neurological damage seen with Parkinson’s disease. The findings appear in the March 1 issue of the Journal of Immunology, a leading scientific journal in the field of immunology. The cause of Parkinson’s disease is the loss
Read more…
(HealthNewsDigest.com) – ST. PAUL, Minn., — New research shows people who regularly take ibuprofen may reduce their risk of developing Parkinson’s disease, according to a study released today that will be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto April 10 to April 17, 2010. The research involved 136,474 people who did not have Parkinson’s disease
Read more…
BY TOM BLACKWELL, NATIONAL POST WITH FILES FROM CANWEST NEWS SERVICE A decade ago, Michael J. Fox predicted Parkinson’s — the disease that has afflicted him for 17 years — would be cured in 10 years. No such breakthrough is close, but new research at the University of Windsor could halt its advance. Each time University of Windsor graduate student
Read more…
The largest epidemiological study of Parkinson’s disease in the United States has found that the disease is more common in the Midwest and the Northeast and is twice as likely to strike whites and Hispanics as blacks and Asians. The study, based on data from 36 million Medicare recipients, is both the first to produce any significant information on patterns
Read more…
Share this:EmailPrintFacebookStumbleUpon
By Michael Smith, North American Correspondent, MedPage Today Published: January 20, 2010 Reviewed by Zalman S. Agus, MD; Emeritus Professor University of Pennsylvania School of Medicine and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner Earn CME/CE credit for reading medical news Treadmill training can improve the impaired walking associated with Parkinson’s disease, researchers said. The technique leads to improvements
Read more…
When we get to New Year’s Eve we become nostalgic, and usually reflect on the year just passed. This past New Year’s Eve added the dimension of a decade of time and the reflection grew deeper as you pondered the ten year time span. Just think about the events. Probably the most indelible is the terrorist attacks of 2001. Do
Read more…
Share this:EmailPrintFacebookStumbleUpon
On April 24, 2010, Mike Justak will join the thousands gathering in New York City’s Central Park and walk in support of those with Parkinson’s disease. The New York walk is the largest of its kind. Details on Mike’s effort can be found at: MikesWalkforPD.com Share this:EmailPrintFacebookStumbleUpon
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson’s disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson’s disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. “Statins are one of the most widely used
Read more…
Researchers at Iowa State University have found an essential key to possibly cure Parkinson’s disease and are looking for others. Anumantha Kanthasamy, a distinguished professor of biomedical sciences and W. Eugene and Linda R. Lloyd Endowed Chair in Neurotoxicology at the ISU College of Veterinary Medicine, has been working to understand the complex mechanisms of the disease for more than
Read more…
By John Gever, Senior Editor, MedPage Today Final results from a closely watched trial of rasagiline (Azilect) in Parkinson’s disease suggested the drug slowed the illness’s progression, study leaders said, but outside experts voice doubts. Patients receiving 1 mg/day of rasagiline for 72 weeks showed a mean 2.82-point worsening of symptoms compared with a 4.52-point change among patients in a
Read more…
SAN DIEGO—A simple smell test may soon be used to aid the diagnosis of Parkinson’s disease and to identify relatives and others at risk for the disease. Research on the use of smell tests in Parkinson’s disease was presented at the 58th Annual Meeting of the American Academy of Neurology. Since at least 1955, hyposmia has been known to occur
Read more…
Click the article title for link to see summary of the Fox appearance on Oprah. Clip courtesy of “A Current Affair.” LINK TO VIDEO CLIP Share this:EmailPrintFacebookStumbleUpon
Teams of scientists from Australia and the United States have used yeast and mammalian cells to discover a connection between genetic and environmental causes of Parkinson’s disease (PD). Yeasts are single cell organisms, used widely in biological research because their structure resembles that of cells found in animals and humans. Yeasts share many genes, or their functional equivalents, with humans
Read more…
By Rick Nauert, Ph.D. Senior News Editor Reviewed by John M. Grohol, Psy.D. on January 27, 2009 A new study offers tantalizing hope that the drug rasagiline can do what no other medication for Parkinson’s disease does — slow the progression of the devastating degenerative brain disease. The study investigated the long-term effects of rasagiline (Azilect) on newly diagnosed patients
Read more…
Tiny capsules implanted in the brain have been developed to reverse the effects of Parkinson’s disease. The capsules contain pig cells that produce chemicals and proteins to help repair damaged brain tissue.Early results suggest the treatment could halt the tremors and stiffness that blight Parkinson’s sufferers. Parkinson’s is caused by the loss of nerve cells in the brain that control
Read more…
Tiny capsules implanted in the brain have been developed to reverse the effects of Parkinson’s disease. The capsules contain pig cells that produce chemicals and proteins to help repair damaged brain tissue.Early results suggest the treatment could halt the tremors and stiffness that blight Parkinson’s sufferers. Parkinson’s is caused by the loss of nerve cells in the brain that control
Read more…
AFFiRiS has started pre-clinical development of a Parkinson’s vaccine. The vaccine, known as PD01, can be used to target a specific protein that is closely associated with the causes of this degenerative neurological disease. Excellent product candidates from discovery studies have prompted the company to file a patent application and proceed immediately with development. Similarly positive results from external assessments
Read more…
The Bernard Madoff scandal has hit a high-profile Parkinson’s disease research project at the University of Pittsburgh. The Pittsburgh Institute for Neurodegenerative Diseases operated for five years with a $750,000 annual grant from the Picower Foundation, which shut down last week because of the $50 billion fraud scheme that wiped out investors around the world. The foundation notified Pitt officials
Read more…
David Zid has announced he will conduct his exercise program featured in his Parkinson’s Disease exercise book, “Delay the Disease”, on November 9 in Plymouth Minnesota’s Plymouth Creek Center. To reserve your spot send email request to: reserve_zid@pfp-mn.org or go to www.pfp-mn.org for details. Share this:EmailPrintFacebookStumbleUpon
Parkinson’s-Specific Exercise Plan Restoring Lives COLUMBUS, Ohio, Dec. 6 /PRNewswire/ — Since the spring release of his new book and instructional DVD, Delay the Disease – Exercise and Parkinson’s Disease, David Zid delights in the positive response from participants whose lives are enhanced thanks to following his daily fitness program. Participants worldwide are thrilled that their Parkinson’s symptoms have been
Read more…
theanchoressonline.com — Great – and, for anyone following the stunning medical advances being made thanks to ADULT Stem Cell Research – unsurprising news on the Parkinson ’s front. Just as numerous spinal cord injuries are being successfully treated with ASC taken from nasal cavities, it looks there sufferers of Parkinson’s Disease may be helped, too. Share this:EmailPrintFacebookStumbleUpon
By Medical reporter Sophie Scott Posted Mon Jun 16, 2008 4:45pm AEST Australian scientists have discovered that stem cells found in the back of a patient’s nose can produce the chemical which is missing in people with Parkinson’s disease. Parkinson’s disease occurs when the brain cells that produce the chemical dopamine stop working. Without dopamine, nerve cells cannot function, leading
Read more…
last updated: 11 April 2008 A surge of Parkinson’s disease linked to rapidly ageing populations worldwide will severely tax health care systems in coming decades, experts warned ahead of World Parkinson’s Disease Day. AdvertisementThe burden of Parkinson’s and other neurodegenerative diseases that strike later in life will be amplified, experts say, by breakdown of informal, home-based care networks that are
Read more…
Scientists in Finland believe they have found a protein that can prevent the degeneration of cells that produce dopamine. In a patient with Parkinson’s, these nerve cells, which produce dopamine, are destroyed. The scientists believe this chemical may lead the way to treatment which would encourage the damaged cells to recover. Drugs today do not prevent the degeneration of nerve
Read more…
A new study reports that when Parkinson’s patients took tango classes, their balance improved. Problems with walking and balance are common among people with the disease. For the study, 19 Parkinson’s patients were given either 20 tango classes or 20 exercise classes. The exercise class consisted of one hour of movement, either in chairs or using chairs for support. The
Read more…
New Results Mark Successful Stem Cell Therapy for Parkinson’s Disease NewswireToday – /newswire/ – Pharr, TX, United States, 02/20/2008 – Parkinson’s Disease is a progressive movement disorder marked by tremors, rigidity, slow movements (bradykinesia), and posture instability. It occurs when cells in one of the movement-control centers of the brain begin to die for unknown reasons. PD was first noted
Read more…
An unusually serious one, this. Research shows that tango can actually be good for people suffering from Parkinson’s Disease, a degenerative disease of the nervous system. Researchers Gammon M. Earhart, Ph.D., assistant professor of physical therapy, and Madeleine E. Hackney, a predoctoral trainee in movement science, compared the effects of Argentine tango dance classes to exercise classes on functional mobility
Read more…
PFP Inc. , in forging “Partnerships for Parkinson’s” has joined with Prodege to create a method of funding the 501 (c) 3 organization through web search engines. Download the special toolbar at the following site: http://PartnershipsforParkinsonsPFPInc.prodege.vmn.net/ Install and every time you use the search box a donation is made to PFP Inc! Share this:EmailPrintFacebookStumbleUpon
NEW YORK, Jan. 4 /PRNewswire-USNewswire/ — The Michael J. Fox Foundation has committed up to $3.8 million for the development of a gene silencing therapeutic to treat Parkinson’s disease by reducing expression of the protein alpha-synuclein. A team of researchers led by Matt Farrer, PhD, of Mayo Clinic Jacksonville (Florida) with collaborators at Alnylam Pharmaceuticals and The Parkinson’s Institute and
Read more…
A successful treatment for Parkinson’s disease, a neurodegenerative disorder that affects 1 percent of the world’s population and (an estimated 500,000 people in the U.S.) aged 60 years and over, may be “in our sights now,” says Ronald McKay, a researcher at the National Institutes of Health (NIH). McKay’s optimism stems from new research that shows that a gene, known
Read more…
Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells. Replacing these cells is considered a promising therapeutic strategy. Although DA cell-replacement therapy by transplantation of human fetal mesencephalic tissue has shown promise in clinical trials, limited tissue availability means that other sources of these cells are needed. Now, Ernest Arenas and colleagues
Read more…
The authors investigated the effects of green tea polyphenols, a group of naturally occurring chemical substances found in plants that have antioxidant properties, in an animal model of Parkinson’s disease. Parkinson’s disease is a progressive, degenerative disorder of the central nervous system, resulting from the loss of dopamine-producing brain cells, and there is presently no cure. According to Dr. Baolu
Read more…
Dr. Pahan and colleagues from Rush, along with researchers at the University of Nebraska Medical Center, Omaha, and Yale University, New Haven, have successfully used a peptide to reverse biochemical, cellular and anatomical changes in mice with Parkinson’s Disease and have had success in preventing the disease from progressing. Pahan explained that after intraperitoneal injection (injection into the abdomen of
Read more…
Turns out the folks from the Department of Neurology at the University of Florida know their way around a kitchen as well as they know their way around the nervous system. Continue to 2nd paragraph Karen Voyles/The Gainesville Sun A member of the Chrome Divas women’s motorcycle riding organization dishes up a bowl of chili Saturday afternoon during the 6th
Read more…
Los Angeles — A U.S. study suggests over-the-counter medicines called non-steroidal anti-inflammatory drugs, or NSAIDs, may reduce a person’s risk of Parkinson’s disease. The study involved 579 men and women, half of whom had Parkinson’s. The participants were asked if they had taken aspirin and if they had taken non-aspirin NSAIDs, such as ibuprofen, once a week or more at
Read more…
Researchers have successfully used a peptide to reverse biochemical, cellular and anatomical changes that occur in the brains of mice with Parkinson’s disease (PD), and report success in preventing the disease from progression. “This could be a new approach to halt disease progression in PD patients,” said study author Kali Pahan, PhD, professor of neurological sciences at Rush University Medical
Read more…
A Swedish expert has predicted that the use of stem cells in curing the brain-wasting Parkinson’s disease will be possible within five years. The Korea Times reported that Olle Lindvall, a professor of Lund University in Sweden and a brain cell therapist, made the prediction on Thursday in Seoul. Lindvall is in the South Korean capital attending a symposium on
Read more…
02 Nov 2007 – Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson’s disease – a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders. Currently, the main approach for treating Parkinson’s disease is to replace
Read more…
ST. LOUIS (UPI) — U.S. medical scientists said they have identified the key brain chemical that causes Parkinson’s disease. Researchers at the Saint Louis University School of Medicine said their finding might lead to new and far more effective therapies to treat one of the most common and debilitating of neurological disorders. Currently, the main approach for treating Parkinson’s disease
Read more…
by MT Bureau – October 27, 2007 – 0 comments Tucson — A U.S. researcher says he thinks he knows why Parkinson’s patients treated with Deep Brain Stimulation often exhibit compulsive behaviors. Michael Frank, of the Laboratory for Neural Computation and Cognition at The University of Arizona, and colleagues say DBS interferes with the brain’s innate ability to deliberate on
Read more…
Main Category: Alzheimer’s / Dementia News Article Date: 11 Oct 2007 – 10:00 PDT email to a friend printer friendly view / write opinions rate article newsletters Visitor Ratings: Healthcare Professional: General Public: >> rate this article In a finding that may lead to potential new treatments for diseases such as Alzheimer’s and Parkinson’s, researchers at the Picower Institute for
Read more…
Dr. Jay Adlersberg (New York – WABC, October 12, 2007) – An interesting lesson shared on the Upper East Side. The wife of boxing legend Muhammad Ali spoke about her experience dealing with Parkinson’s disease. Eyewitness News Dr. Jay Adlersberg was there and joins us with more. Somehow the champ is always the champ, in the ring or years later
Read more…
Monday, October 08, 2007 ROCHESTER, Minn. — Immediate relatives of people who have Parkinson’s disease are at greater risk of developing cognitive impairment or dementia than people who have no first-degree relatives (brother, sister, mother, father, son or daughter) with Parkinson’s disease, according to a new study by Mayo Clinic. The risk is particularly increased for relatives of patients who
Read more…
By James Langston ATASCADERO, California — In Monterey County Jail, in the spring of 1981, a 21-year-old drug dealer and junkie named Toby Govea lay in bed shaking violently and uncontrollably. Thanks to a bad batch of homemade heroin, Govea had developed symptoms of Parkinson’s Disease, an incurable neurological illness that causes muscle rigidity, tremors and eventually loss of movement.
Read more…
Grant from the Michael J. Fox Foundation Funds Project Researchers from the University of Maryland School of Medicine and the Baltimore VA Medical Center have launched a study to see if exercising several times a week will help people with Parkinson’s disease improve their walking and balance. A $750,000 grant from the Michael J. Fox Foundation is funding this multi-year
Read more…
Lonnie Ali has been a caregiver to her husband, Muhammad Ali, who has been in the fight of his life since being diagnosed with Parkinson’s disease (PD) more than 20 years ago. Throughout this challenging time she has been in his corner, and now Lonnie is championing Fight For MORE, a national educational campaign that provides resources and tools for
Read more…
Consumers searching for information on Parkinson’s disease, a progressive neurological condition that affects more than 1.5 million Americans, now have a new online destination. The Parkinson’s Disease Blog Network (http://www.parkinsonsblognetwork.com) is the first site to centralize these individual perspectives, helping consumers to quickly identify the most relevant and useful information for any given situation. Oversight by an advisory board of
Read more…
By ARENA WELCH Eagle Staff Writer Two nationally recognized researchers hope to help the public break through the cloud of mystery surrounding Parkinson’s disease next week during a neurosciences symposium in College Station, officials said. “Parkinson’s is still a disease with a lot of question marks around it,” said Tim Ottinger, a spokesman for St. Joseph Regional Health Center. “Although
Read more…
This is an informational page on Parkinson’s disease. For information on the social security disability process, including advice, tips and how the disability evaluation system works at the intial claim, reconsideration, and disability hearing levels, you may follow the link at the top of this page that leads to Disability Secrets.com or, if you are considering representation, you may scroll
Read more…
New Parkinson’s Disease Online Resource Now Available From: Medical News Today Aug 2, 2007 Consumers searching for information on Parkinson’s disease, a progressive neurological condition that affects more than 1.5 million Americans, now have a new online destination. The Parkinson’s Disease Blog Network (http://www.parkinsonsblognetwork.com) is the first site to centralize these individual perspectives, helping consumers to quickly identify the most
Read more…
Merck KGaA and its development partner, Newron, say that a late-stage study of their experimental therapy for Parkinson’s failed to demonstrate any significant effect. But the two developers refuse to walk away from safinamide. Researchers are planning to mount new trials with lower doses to find the right formula. “The primary endpoint, time to intervention, did not reach statistical significance
Read more…
Scientists have discovered a protein which may help to slow, or even reverse symptoms of Parkinson’s disease. Parkinson’s destroys nerve cells that produce the brain chemical dopamine, causing movement and balance problems. Finnish researchers found the new molecule can prevent degeneration of these cells - and help damaged cells start to recover. Their paper, featured in Nature, showed symptoms eased in rats
Read more…
Medical Research News Published: Sunday, 15-Jul-2007 The Michael J. Fox Foundation (MJFF) has awarded two research grants to UAB (University of Alabama at Birmingham) researchers to investigate novel approaches to treat Parkinson’s disease. UAB scientists will collaborate with researchers from the University of Alabama (UA) on one of the two grants, part of the Foundation’s 2007 Target
Read more…
By Steven Edwards Complementing today’s Wired story on the pharmaceutical benefits of nicotine, a study published in July’s Archives of Neurology reports that smoking may reduce the risk of developing, or delay the onset of, Parkinson’s disease. Smaller benefits were detected in former smokers. The authors found that smokers were less likely to get Parkinson’s, and those who smoked more
Read more…
HealthDay By Madeline Vann Thursday, July 5, 2007 THURSDAY, July 5 (HealthDay News) — Disruption of a key cellular enzyme may be a root cause of Parkinson’s disease, a new study finds. Parkinson’s disease occurs when neurons that produce dopamine die. Dopamine is a neurochemical that allows the body to move with smooth coordination. When 80 percent of the neurons
Read more…
“Ceregene, Inc. and Genzyme Corporation today announced that they have entered into a partnership for the development and commercialization of CERE-120, Ceregene’s proprietary lead program for the treatment of Parkinson’s disease. Under the terms of the agreement, Genzyme will pay Ceregene a $25 million up-front payment in exchange for certain partnership-related expenses. Ceregene will also be entitled to development-related milestone
Read more…
PARIS (Thomson Financial) – The first attempt at gene therapy against Parkinson’s disease has yielded promising results and is safe, according to early data to appear in the British journal The Lancet on Saturday. The pilot study among 11 men and one woman with Parkinson’s disease in New York involved a ‘Trojan horse’ technique. This entailed taking a gene and
Read more…
by Sea Stachura, Minnesota Public Radio June 15, 2007 St. Paul, Minn. — Dr. Demetrius Maraganore did what most disease researchers do when they’re searching for genetic links in a disease: he took it one gene at a time. But no matter what gene he looked at, his findings weren’t that conclusive. “If I told you your risk for Parkinson’s
Read more…
http://nationmultimedia.com:80/world…ewsid=30036474 PARIS – A drug tested on lab mice slows and may even halt the progress of Parkinson’s, offering the brightest pharmacological hope in decades of rolling back this tragic disease, US researchers report on Sunday. Isradipine, already licensed for treatment for high blood pressure, rejuvenated ageing dopamine cells, the brain cells whose death causes Parkinson’s, they say. The outcome
Read more…
Science Daily — Northwestern University researchers have discovered a drug that slows — and may even halt — the progression of Parkinson’s disease. The drug rejuvenates aging dopamine cells, whose death in the brain causes the symptoms of this devastating and widespread disease. D. James Surmeier, the Nathan Smith Davis Professor and chair of physiology at Northwestern University’s Feinberg School
Read more…
15/06/2007 Financial Times By: Presswatch A drug to beat Parkinson’s Researchers have discovered a drug that slows, and may even halt, the progression of Parkinson’s disease. Isradipine, widely used for hypertension and stroke, rejuvenates ageing dopamine cells, whose death in the brain causes the symptoms. Isradipine may also help people who already have Parkinson’s disease, according to the team of
Read more…
Parkinson’s is a debilitating disease that affects a person’s movement, strength, and balance, and in many ways is still a mystery to doctors and scientists. One thing that is becoming more clear, however, is that regular physical exercise seems to help slow the progression of the symptoms and delay the effects of the disease. And now a certified trainer, David
Read more…
Written by News Desk Sunday, 03 June 2007 (NAPSI)-Lonnie Ali has been a caregiver to her husband, Muhammad Ali, who has been in the fight of his life since being diagnosed with Parkinson’s disease (PD) more than 20 years ago. Throughout this challenging time she has been in his corner, and now Lonnie is championing Fight For MORE, a
Read more…
the scientists could show that Parkin prevents the induction of neuronal cell death. As reported in the “Journal of Neuroscience”, the protein activates a survival mechanism which had been known for its prominent role in immune response. Usually, Parkinson’s disease occurs after the age of 50 and in Germany about 400,000 people are affected. It is characterized by a decline
Read more…
The Parkinson Pipeline Project is a grassroots group of advocates whose goal is to provide the patient perspective in the treatment development process. Through education, consultation, and participation with all stakeholders, including industry and the FDA, the Parkinson Pipeline Project hopes to increase clinical trial participation and accelerate approved treatment options. New PD treatments are followed from pre-clinical development to
Read more…
EH News Bureau Manipal Hospital, Bangalore claimed of having discovered stem cells that help in recovery of a patient suffering from Parkinson’s Disease (PD). Manipal used the benefits of stem cell research and helped US national Andrew Kisana get a new hope. Andrew, who was suffering from PD for more than 15 years, came to Manipal Hospital as a last
Read more…
Science Daily — Small doses of the antioxidant coenzyme Q10 appear to increase blood levels of this naturally occurring compound in patients with Parkinson’s disease, but does not improve Parkinson’s disease symptoms, according to an article that will appear in the July 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals. Parkinson’s disease is a neurodegenerative disorder
Read more…
Ijeoma Eleazu, PharmD Today the FDA approved the first ever skin patch for treating the symptoms of early Parkinson’s disease. Neupro (Rotigotine) belongs to a class of drugs known as dopamine agonists. The patch, manufactured by Schwarz Pharma, delivers a continuous dose of the medication through the skin over a 24-hour period and will need to be replaced every day.
Read more…
A Conversation With Susan L. Lindquist On the Trail of Parkinson’s, Through Yeast Cells By CLAUDIA DREIFUS Published: April 24, 2007 Among other accolades, she is a Howard Hughes Medical Investigator, a member of the National Academies of Science and the American Academy of Arts and Sciences, and the 2006 recipient of the Sigma Xi William Procter Prize for Scientific
Read more…
Charles Enman Citizen Special Tuesday, April 24, 2007 Given enough funding, a cure for Parkinson’s disease could be in the hands of physicians within 10 years, a noted researcher says. “It would take money and researchers are in desperate times financially — but I’m fairly certain we could have a cure within a decade,” said Jackalina Van Kampen, who will
Read more…
Regular exercise could be key to reducing your risk of Parkinson’s disease. Harvard researchers studied nearly 150,000 people for 10 years and found those who exercised at least half an hour per day had a reduced risk of Parkinson’s. The research will be presented at the American Academy of Neurology’s annual meeting in Boston, April 28 – May 5. Harvard
Read more…
A new study has confirmed a relationship between consuming large amounts of dairy products and an increase in the rate of Parkinson’s disease in men, but the reason for this relationship remains a puzzle. Researchers found that among more than 130,000 U.S. adults followed for 9 years, those who ate the largest amount of dairy foods had an increased risk
Read more…
Source: National Institute of Neurological Disorders and Stroke (NINDS) The NINDS is a component of the National Institutes of Health in Bethesda, Maryland, and is the nation’s primary supporter of biomedical research on the brain and nervous system. 1. Shults CW, Oakes D, Kieburtz K, Beal F, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti
Read more…
This article was aggregated from Middle East Analysis Michael J. Fox Foundation puts faith in Israeli Parkinson’s research By Laura Goldman April 15, 2007 Two Israeli companies working on treatments for Parkinson’s Disease have been awarded grants by the Michael J. Fox Foundation. Cell Cure Neurosciences and Proneuron Biotechnologies were awarded $660,000 and $430,000 respectively under a new program started
Read more…
yesterday was the the 252nd birth anniversary of james parkinson,an english physician and surgeon. april 11 is celebrated every year as world parkinson’s day. he was born on 11th april 1755. dr james parkinson wrote “an essay on the shaking palsy”, in which symptoms of this disease were documented which later on came to be known as parkinson’s disease. parkinson’s
Read more…
By NICHOLAS BAKALAR Published: January 2, 2007 Very low levels of LDL, the so-called bad cholesterol, may be linked with an increased risk for Parkinson’s disease, a new study suggests. Researchers compared blood levels of LDL cholesterol in 124 Parkinson’s patients with a control group of 112 of their healthy spouses. Compared with people in the highest one-quarter in LDL
Read more…
Newsday Patients with Parkinson’s disease have long battled the roller-coaster-like effects of the current medicines: Over the course of the disease, the gold standard treatment, L-dopa, doesn’t control the tremors, stiffness, slowness and walking problems, and many don’t know when during the day it will stop working. What’s more, L-dopa’s side effects — uncontrolled dance-like movements — can be as
Read more…
ROCHESTER, N.Y., April 5 /PRNewswire/ — Researchers with the National Institute of Neurological Disorders and Stroke (NINDS) have initiated one of the largest-ever Parkinson’s disease clinical trials. The study, which involves more than 50 sites and will enroll over 1,700 patients in the U.S. and Canada, is intended to test a new drug therapy, developed by Palo Alto-based Avicena Group,
Read more…
Diet. Eating a well-balanced, nutritious diet can be beneficial for anybody. But for preventing or curing Parkinson’s disease, there does not seem to be any specific vitamin, mineral, or other nutrient that has any therapeutic value. A high protein diet, however, may limit levodopa’s effectiveness. Despite some early optimism, recent studies have shown that tocopherol (a form of vitamin E)
Read more…
The degeneration of brain cells that occurs in Parkinson’s disease can be caused by either externally provoked cell death or internally initiated suicide when the molecule that normally prevents these fatal alternatives is missing, according to results of studies in mouse models by St. Jude investigators. In Parkinson’s disease, nerve cells in the part of the brain called the substantia
Read more…
Seattle Post-Intelligencer ^ | March 29, 2007 | RANDOLPH E. SCHMID Posted on 03/30/2007 7:22:48 PM PDT by neverdem AP SCIENCE WRITER WASHINGTON — A drug used by several thousand patients with Parkinson’s disease is being pulled from the market because of reports of heart valve damage. The Food and Drug Administration said Thursday that pergolide, sold under the name
Read more…
By JOSEPH BERGER Published: November 26, 2006 DAVID EGER does not exaggerate the tremor in his left hand nor the rigid leg that gives him a limp. So he was not amused when Rush Limbaugh accused Michael J. Fox of exaggerating his Parkinson’s symptoms in the actor’s commercial on behalf of political candidates who favor the stem-cell research that might
Read more…
ROME (AP) It’s one of the Roman Catholic Church’s closely guarded secrets: the identity of the French nun whose testimony of an inexplicable cure from Parkinson’s disease is likely to be accepted as the miracle the Vatican needs to beatify Pope John Paul the Second. The nun is expected to be in Rome for ceremonies Monday marking the second anniversary
Read more…
The story of each person’s journey with Parkinson’s disease is as unique as the individual. An estimated 1 million Americans have the disease — more than 1,500 in Vermont alone.Most people associate Parkinson’s with Michael J. Fox. The actor’s tremors and difficulty speaking have put a public face on a disease that is rarely discussed.What causes Parkinson’s is unknown, and
Read more…
Parkinson’s Disease Does Not Have to Come Between You and Your Loved One If you are a caregiver you probably have a close relationship with the person you are caring for. Whether it’s your spouse, your mother or father, friend or other relative, it’s very important for you both to realize that the problems you are facing are not from
Read more…
Ali’s legacy ranks with the greatest By all accounts, Muhammad Ali turned 65 in peace and quiet Wednesday. There was a time when those words peace, quiet and Ali would not have been mentioned in the same paragraph, but “The Greatest” is fighting a fight he never asked for against Parkinson’s disease. Source: www.chicagotribune.com Do statin users risk Parkinson’s
Read more…